Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LifeStance Health GroupLFST -0.65%54 Future 3-5Y EPS without NRI Growth Rate is 144.15 as of Jul. 31, 2026. GuruFocus rates LFST with a GF Score™ of 54/100 and a GF Value™ of $8.34 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 197 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 97.46% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
LifeStance Health Group (NAS:LFST) Future 3-5Y EPS without NRI Growth Rate Explanation
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
LifeStance Health Group Future 3-5Y EPS without NRI Growth Rate Related Terms
LFST vs CON, BKD, NHC: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Future 3-5Y EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 144.15 mean?
LifeStance Health Group (LFST) has a Future 3-5Y EPS without NRI Growth Rate of 144.15 as of Jul. 31, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for LifeStance Health Group and its competitors. According to the industry distribution chart, LifeStance Health Group ranks #5 out of 197 companies in the Healthcare Providers & Services industry, placing it in the top 2.5%.
Is LifeStance Health Group's Future 3-5Y EPS without NRI Growth Rate too high?
LifeStance Health Group's current Future 3-5Y EPS without NRI Growth Rate is 144.15. The Healthcare Providers & Services industry median Future 3-5Y EPS without NRI Growth Rate is 16.40. LifeStance Health Group's value of 144.15 is 779% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #5 out of 197 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, LifeStance Health Group has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Future 3-5Y EPS without NRI Growth Rate compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #5 out of 197 companies for Future 3-5Y EPS without NRI Growth Rate. This places LifeStance Health Group in the top 3% of its industry — outperforming the majority of peers. The industry median Future 3-5Y EPS without NRI Growth Rate is 16.40. LifeStance Health Group's value of 144.15 is 779% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median Future 3-5Y EPS without NRI Growth Rate among Healthcare Providers & Services companies is 16.40, based on 197 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Future 3-5Y EPS without NRI Growth Rate of 144.15 is 779% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Future 3-5Y EPS without NRI Growth Rate is 16.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Future 3-5Y EPS without NRI Growth Rate is 144.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.34, compared to a current price of $10.66 — trading 27.8% above its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 144.15 and 779% above the Healthcare Providers & Services industry median of 16.40. LifeStance Health Group's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Future 3-5Y EPS without NRI Growth Rate is 144.15 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.66 is trading 27.8% above its estimated GF Value™ of $8.34.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
Future 3-5Y EPS without NRI Growth Rate: 144.15
GF Value™: $8.34 vs. price of $10.66 (27.8% above fair value)
Industry Position: 779% above the Healthcare Providers & Services median (#5 of 197)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
54GF Score
Get the complete analysis for LFST
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
